Fundz

Thunder Biotech reported raising $9.98 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEAug 22, 2022Late filing, first sale Sep 30, 2019$10M of $10M raised

Amount Raised

$9.98 Million

$9.98 Million sold, per SEC Form D (first sale Sep 30, 2019)

Round Type

Venture

ProvoBiotechnologyBiotechnology Research

Quick answer

Thunder Biotech raised $9.98 Million in a funding round, dated September 30, 2019. Thunder Biotech is based in Provo, Utah, United States.

How much did Thunder Biotech raise?
Thunder Biotech raised $9.98 Million in a funding round on September 30, 2019.
What does Thunder Biotech do?
Thunder Biotech, Inc. is an immune-oncology company developing patented MOTO-CAR™ technology - genetically engineered CAR macrophages - that help cancer patients' immune cells recognize and attack solid tumors.
Where is Thunder Biotech based and how big is it?
Thunder Biotech is based in Provo, Utah, United States.
Who are the decision-makers at Thunder Biotech?
Fundz holds 1 contact at Thunder Biotech, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology Research and Biotechnology around the same time

Companies in the same sectors as Thunder Biotech that raised within 45 days of this round, from Fundz verified event records.

  • BlueWillow Biologics raised $800K (Seed) on September 5, 2019.
  • eGenesis raised $100M on November 14, 2019.
  • Cupron raised $1.8M (Seed) on November 14, 2019.
  • Luminary Therapeutics raised $5.2M on November 14, 2019.
  • ISOThrive raised $4M on November 14, 2019.
  • Vyriad raised $24M on November 14, 2019.

Who to call at Thunder Biotech, and when

A new round usually means Thunder Biotech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Thunder Biotech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Thunder Biotech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Thunder Biotech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Thunder Biotech

Location

180 North University Avenue

Provo, Utah, United States

About

Thunder Biotech, Inc. is an immune-oncology company developing patented MOTO-CAR™ technology - genetically engineered CAR macrophages - that help cancer patients' immune cells recognize and attack solid tumors. Traditional cancer treatments— like surgery, radiation, and chemotherapy—are often ineffective, invasive, and difficult to tolerate. Thunder Biotech is designing MOTO-CAR™s to be a more effective and humane therapy. Thunder Biotech's MOTO-CAR™s re-educate Tumor Associated Macrophages and restore their M1 ability to recognize and eliminate tumor cells. In addition, MOTO-CAR™s are armed with tumor specific receptors that directly adhere to the tumor cell surface allowing them to initiate tumor cell destruction and recruit the natural T cell response engaging them to eliminate the tumor. This T cell response will then provide the body with a memory response preventing tumor recurrence.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Thunder Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJeff H., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Thunder Biotech's next move

See what Strategic adds

Thunder Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.